Breakthrough in Cancer Gene Therapy: Deciphering the Sulfation Code of Glycosaminoglycans
Researchers at the Indian Institute of Science Education and Research have made a significant discovery in the field of biotechnology, specifically in cancer gene therapy. By understanding the sulfation pattern of glycosaminoglycans (GAGs), such as heparan sulfate (HS) and chondroitin sulfate (CS), scientists have developed a potential drug- or gene-delivery system that can induce precise homing of nanoparticles in tumor cells or neurons. This breakthrough has the potential to revolutionize cancer treatment and gene therapy.
Key Takeaways:
- Researchers at the Indian Institute of Science Education and Research have discovered that specific sulfation patterns on HS and CS regulate receptor-mediated homing of nanoprobes in primary and secondary cells.
- The study found that aggressive cancer cells, such as MDA-MB-231, displayed a strong uptake of GAG-nanoprobes compared to mild or moderately aggressive cancer cells.
- The researchers also found that U87 cells, olfactory bulb, and hippocampal primary neurons showed selective or preferential uptake of CS-E-coated nanoprobes compared to other GAG-nanoprobes.
- Mechanistic studies revealed that the 4,6-O-disulfated-CS nanoprobe used the CD44 and caveolin-dependent endocytosis pathway for uptake.
- The research concluded that these findings could lead to new opportunities to use GAG nanoprobes in nanomedicine.
- The study was peer-reviewed and published in Chemistry - A European Journal in 2022.
Statistics:
- 4,6-O-disulfated-CS nanoprobe was used in the study.
- CD44 and caveolin-dependent endocytosis pathway was used by the 4,6-O-disulfated-CS nanoprobe for uptake.
- The study found that aggressive cancer cells, such as MDA-MB-231, displayed a strong uptake of GAG-nanoprobes compared to mild or moderately aggressive cancer cells.
- U87 cells, olfactory bulb, and hippocampal primary neurons showed selective or preferential uptake of CS-E-coated nanoprobes compared to other GAG-nanoprobes.
Sources:
- Sulfation of Heparan and Chondroitin Sulfate Ligands Enables Cell-Specific Homing of Nanoprobes. Chemistry - A European Journal, 2022.
- Indian Institute of Science Education and Research Reports Findings in Cancer Gene Therapy (Sulfation of Heparan and Chondroitin Sulfate Ligands Enables Cell-Specific Homing of Nanoprobes). Nanotechnology Weekly. December 26, 2022; p 381.